Nihon Kohden Corp
TSE:6849

Watchlist Manager
Nihon Kohden Corp Logo
Nihon Kohden Corp
TSE:6849
Watchlist
Price: 1 964 JPY -2.51% Market Closed
Market Cap: 335.8B JPY

Nihon Kohden Corp's latest stock split occurred on Jun 27, 2024

The company executed a 2-for-1 stock split, meaning that for every share held, investors received 2 new shares.

Before the split, Nihon Kohden Corp traded at 4636 per share. Afterward, the share price was about 2333.4661.

The adjusted shares began trading on Jun 27, 2024. This was Nihon Kohden Corp's 2nd stock split, following the previous one in Mar 27, 2015.

Last Splits:
Jun 27, 2024
2-for-1
Mar 27, 2015
2-for-1
Pre-Split Price
2 302.1811 4 636
Post-Split Price
2 333.4661
Before
After
Last Splits:
Jun 27, 2024
2-for-1
Mar 27, 2015
2-for-1

Nihon Kohden Corp
Stock Splits History

Nihon Kohden Corp Stock Splits Timeline
Jun 27, 2024
Jun 27, 2024
Split 2-for-1
x2
Pre-Split Price
2 302.1811 4 636
Post-Split Price
2 333.4661
Before
After
Mar 27, 2015
Mar 27, 2015
Split 2-for-1
x2
Pre-Split Price
1 384.435 6 320
Post-Split Price
1 440.6054
Before
After

Global
Stock Splits Monitor

Date Company Split Pre-Split Price Post-Split Price
Apr 1, 2025
I
Icon Energy Corp
NASDAQ:ICON
1-for-40
/40
0.0478 1.912 USD 1.79 1.79 USD
Apr 1, 2025
V
Vortex Energy Corp
CNSX:VRTX
1-for-10
/10
0.075 0.075 CAD 0.11 0.11 CAD
Apr 1, 2025
R
Resource Centrix Holdings Inc
CNSX:RECE
10-for-1
x10
2.4 0.24 CAD 0.24 0.24 CAD
Apr 1, 2025
V
Vortex Energy Corp
OTC:VTECF
1-for-10
/10
0.05 0.5 USD 0.0378 0.0378 USD
Mar 31, 2025
Utime Ltd
NASDAQ:WTO
1-for-10
/10
0.151 1.51 USD 1.58 1.58 USD
Load More

Nihon Kohden Corp
Glance View

Market Cap
323.6B JPY
Industry
Health Care

Nihon Kohden Corp., founded in 1951, has evolved into a pioneering force in the medical technology landscape, blending innovation with a storied heritage. This Tokyo-based firm established its foothold by developing advanced medical electronic devices, initially focusing on EEG (electroencephalography) machines. As medical science rapidly advanced, Nihon Kohden expanded its portfolio to include a range of diagnostic and monitoring equipment. Today, the company's product line encompasses patient monitors, defibrillators, electrocardiographs, and clinical information systems, serving various healthcare domains. This focus on critical care and diagnostics creates consistent demand across global hospitals and clinics, reinforcing its reputation as a dependable partner in medical excellence. Financially, Nihon Kohden's business model thrives on a dual revenue structure: product sales and after-sales service. By manufacturing and distributing complex equipment directly and through a network of distributors, the company captures a significant share of initial capital expenditure in healthcare institutions. Furthermore, it enhances this income by offering ongoing equipment maintenance, training, and customer support, forming long-term relationships with healthcare providers. These services ensure not only a steady revenue stream beyond the initial sale but also brand loyalty and trust in an industry where precision and reliability are paramount. As it continues to innovate, Nihon Kohden's commitment to addressing the evolving needs of healthcare practitioners fortifies its market position and operational success.

Intrinsic Value
1 137.81 JPY
Overvaluation 42%
Intrinsic Value
Price
Back to Top